Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apitox vs Histamine in Knee Osteoarthritis
NCT00949754Phase 2Completed
- Sponsor
- Apimeds Pharmaceuticals US, Inc.
- Start
- Oct 2009
- Primary completion
- Mar 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of apis mellifera venom in osteoarthritis (OA) (2 arms), sponsored by Apimeds Pharmaceuticals US, Inc. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 14 days. Started Oct 2009; status: completed.
02
Drugs
apis mellifera venom
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00949754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949754.